Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Brachytherapy Stories

2013-09-26 16:26:44

IMRIS and Varian developing cancer treatment system with potential to improve accuracy and effectiveness ATLANTA, Sept. 26, 2013 /PRNewswire/ -- IMRIS Inc. (NASDAQ: IMRS; TSX: IM) and Varian Medical Systems (NYSE: VAR) today announced that data presented here earlier this week at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality MR images at each treatment session....

2013-09-23 16:24:08

ATLANTA, Sept. 23, 2013 /PRNewswire/ -- ASTRO Booth #1115 -- The American Board of Radiology Foundation (ABRF) and Varian Medical Systems (NYSE: VAR) today announce that Varian is awarding a $100,000 second year renewal grant to the ABRF, to continue its work establishing a national brachytherapy registry. The registry, which is the first such nationwide modality-based project in radiation oncology, is linked to the American Board of Radiology's (ABR's) Innovation Pathway in...

2013-09-23 12:42:42

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also indicated that the combined treatments produced acceptable levels of toxicity. The randomized, controlled trial studied a total of 147 women in Brazil with stage IIIB squamous cell...

2013-09-23 08:29:09

Learning and Innovation Center (LINC) to draw thousands to Atlanta ATLANTA, Sept. 23, 2013 /PRNewswire/ - Elekta will unveil a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Atlanta. (Photo: http://photos.prnewswire.com/prnh/20130923/CL82461) The Learning and Innovation Center (LINC) is expected to draw clinicians, researchers and health IT...

2013-09-23 08:28:22

Early-stage breast cancer treatment demonstrates high rates of survival and local control. ALISO VIEJO, Calif., Sept. 23, 2013 /PRNewswire/ -- Cianna Medical, Inc., a women's health company, today announced results of two new studies showing excellent longer-term outcomes with the SAVI(®) breast brachytherapy applicator, including low recurrence rates, few toxicities, excellent cosmetic outcomes and high rates of survival. SAVI is a strut-based applicator that delivers accelerated...

2013-09-21 12:22:11

ATLANTA, Sept. 21, 2013 /PRNewswire/ -- Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya(®), a new approach for treating patients with skin cancer. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/62823-elekta-nucletron-esteya-electronic-brachytherapy-treating-skin-cancer (Photo: http://photos.prnewswire.com/prnh/20130921/MM78119) Over the last 30 years, more people were diagnosed with...

2013-09-20 08:25:20

New interface now connects Varian software with Siemens' ARTISTE medical linear accelerators ATLANTA, Sept. 20, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare will showcase a variety of solutions that bring together Siemens' world-class diagnostic imaging technologies with Varian's advanced therapeutic systems for treating cancer with image-guided radiotherapy, radiosurgery, and brachytherapy at the 54(th) annual meeting of the American Society for...

2013-09-18 00:20:41

SENEFFE, Belgium, September 18, 2013 /PRNewswire/ -- Eckert & Ziegler BEBIG announces its support of the brachytherapy program at Saint John Regional Hospital, Saint John, in the province of New Brunswick, Canada, which is part of the Horizon Health Network. The Adult Oncology Centre at Saint John Regional Hospital, employing five Radiation Oncologists and two Medical Oncologists, has been designated as a tertiary centre for Radiation Oncology and is at the...

2013-09-12 08:32:07

Initial clinical results of Elekta's new flagship linear accelerator emerging globally ATLANTA, Sept. 12, 2013 /PRNewswire/ -- Elekta (booth #942) will exhibit its Versa HD(TM) system at the 55(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 22-24 at the Georgia World Congress Center in Atlanta. In the six months since its introduction, Versa HD has been building momentum worldwide, with clinical users reporting exceptional speed and accuracy. Versa HD...

2013-08-23 08:24:13

ATLANTA, Aug. 23, 2013 /PRNewswire/ -- Nucletron, an Elekta company, has signed an agreement with the American Brachytherapy Society (ABS) to continue to support the implementation of a residency-level training program in brachytherapy for radiation oncologists and physicists from the U.S. as well as other countries. Brachytherapy is a form of radiation therapy in which a radiation source is placed inside or next to a tumor requiring treatment. It is commonly used as an effective...